"FDA Safety Surveillance of COVID-19 Vaccines - DRAFT - Working list of possible adverse event outcomes; ***Subject to change***":
- Guillain-Barré syndrome,
- Acute disseminated encephalomyelitis,
- Transverse myelitis,
- Encephalitis/myelitis/encephalomyelitis/meningoencephalitis/meningitis/encephalopathy,
- Convulsions/seizures,
- Stroke,
- Narcolepsy and cataplexy,
- Anaphylaxis,
- Acute myocardial infarction,
- Myocarditis/pericarditis,
- Autoimmune disease,
- Deaths,
- Pregnancy and birth outcomes,
- Other acute demyelinating diseases,
- Non-anaphylactic allergic reactions,
- Thrombocytopenia,
- Disseminated intravascular coagulation,
- Venous thromboembolism,
- Arthritis and arthralgia/joint pain,
- Kawasaki disease,
- Multisystem Inflammatory Syndrome in Children, and
- Vaccine enhanced disease.
No comments:
Post a Comment